Model | Name | Specifications |
HF2016.5 | Cross-type membrance valve trocar | Φ10.5mm |
HF2016.6 | Cross-type membrance valve trocar | Φ5.5mm |
HF2016.8 | Cross-type membrance valve trocar | Φ11mm |
HF2016.9 | Cross-type membrance valve trocar | Φ12.5mm |
HF2016.10 | Cross-type membrance valve trocar | Φ6mm |
HF2016.3 | Cross-type membrance valve trocar with protection | Φ10.5mm |
HF2016.4 | Cross-type membrance valve trocar with protection | Φ5.5mm |
HF2016.7 | Cross-type membrance valve trocar with protection | Φ11mm |
HF2016.28 | Cross-type membrance valve trocar with protection | Φ6mm |
HF2016.29 | Cross-type membrance valve trocar with protection | Φ12.5mm |
FAQ
"Laparoscopic Gastric Cancer Surgery Operation Guidelines (2023 Edition)" has indeed promoted the development of minimally invasive surgical technology. First of all, the guidelines are revised and updated based on research hotspots and high-level evidence-based medical results in recent years. They cover the indications, surgical approaches, lymph node dissection range, digestive tract reconstruction and other aspects of laparoscopic gastric cancer surgery, providing guidance for the popularization and development of laparoscopic gastric cancer surgery technology. In addition, the guidelines also combine the results of more and more high-quality clinical studies in recent years, further supporting the application of laparoscopic technology in the surgical treatment of gastric cancer.
Minimally invasive surgical technology represented by laparoscopic technology is currently an important means of surgical treatment of gastric cancer. With the release and implementation of this guideline, it can better standardize and promote the operation process and technical standards of laparoscopic gastric cancer surgery, thereby promoting the development of minimally invasive surgical technology.
The "Guidelines for Laparoscopic Gastric Cancer Surgery (2023 Edition)" has been revised and updated in detail, mainly based on the "Guidelines for Laparoscopic Gastric Cancer Surgery (2016 Edition)", combined with research hotspots and high-level evidence-based medicine results in recent years. The guidelines take minimally invasive surgical techniques represented by laparoscopic technology as an important means, emphasizing that the indications of laparoscopic technology in the surgical treatment of gastric cancer have received more evidence-based medicine support.
Specific new technologies and updated content include:
The conduct and results of high-quality clinical studies: These studies further support the application of laparoscopic technology in the surgical treatment of gastric cancer.
Support from evidence-based medicine: With the completion of more high-quality clinical studies, the indications of laparoscopic technology in the surgical treatment of gastric cancer have been more widely recognized and applied.
The application of minimally invasive surgical technology in laparoscopic gastric cancer surgery has been significant and has been supported by many clinical studies.
Laparoscopic radical gastrectomy is a minimally invasive surgical method. Compared with traditional open surgery, it has the advantages of less trauma, faster recovery, and beautiful incision.
Many clinical studies have shown that laparoscopic radical gastrectomy is safe, feasible, and effective in the treatment of early gastric cancer. For example, the CLASS-01 study initiated by the Chinese Laparoscopic Gastrointestinal Surgery Research Group (CLASS Research Group) provided the world's first prospective multicenter evidence of the safety and efficacy of laparoscopic surgery for locally advanced gastric cancer. In addition, laparoscopic distal radical gastrectomy is not only safe and effective in the treatment of locally advanced gastric cancer, but also can accelerate the patient's postoperative recovery and shorten the hospital stay.
The advantages of laparoscopic gastric cancer surgery also include little effect on gastrointestinal hormones and a low chance of micrometastasis. These advantages make laparoscopic gastric cancer surgery the most widely used minimally invasive treatment technology for gastric cancer.
The impact of the "Operation Guidelines for Laparoscopic Gastric Cancer Surgery (2023 Edition)" on the development of minimally invasive surgical technology can be analyzed in detail from the following aspects:
The development of minimally invasive surgical technology is inseparable from scientific and technological innovation and the continuous advancement of instruments. As an important part of modern minimally invasive surgery, laparoscopic technology has gradually matured after more than 30 years of development, and continuous innovation in energy platforms, imaging equipment and other fields has made laparoscopic surgery more precise and safe. Therefore, the "Operation Guidelines for Laparoscopic Gastric Cancer Surgery (2023 Edition)" may further promote the application and development of these technologies and promote the overall improvement of minimally invasive surgical technology.
With the increase in the penetration rate of minimally invasive surgery, the domestic minimally invasive surgical instruments and accessories (MISIA) market has ushered in explosive growth, and the market size is expected to reach 23.8 billion yuan in 2023. This shows that minimally invasive surgical technology is increasingly widely used in clinical practice, and market demand is also increasing. The release and implementation of the "Operation Guidelines for Laparoscopic Gastric Cancer Surgery (2023 Edition)" may further promote this trend and promote the sales and research and development of related instruments and consumables.
In recent years, laparoscopic technology has been widely used in gastrointestinal surgery and has become increasingly mature. The "Laparoscopic Gastric Cancer Surgery Operation Guidelines (2023 Edition)" helps to improve the standardization and normalization of surgery by standardizing and guiding specific surgical operation procedures, thereby improving surgical results and patients' postoperative quality of life. In addition, the guidelines may also promote more doctors to master and apply laparoscopic technology and promote its popularization in a wider range of regions and hospitals.
Events such as the 2023 Bund Surgery Forum focus on the innovation and development of minimally invasive surgery, showing the latest progress and future development direction of minimally invasive surgical technology. The release of the "Laparoscopic Gastric Cancer Surgery Operation Guidelines (2023 Edition)" can serve as an important reference for these academic exchange activities, helping more doctors understand and learn the latest surgical techniques and methods, thereby promoting technological progress and knowledge updates in the entire industry.
The impact of the "Laparoscopic Gastric Cancer Surgery Operation Guidelines (2023 Edition)" on the development of minimally invasive surgical technology is mainly reflected in technological innovation, market expansion, optimization of surgical methods, and academic exchanges.
The latest standard for the extent of lymph node dissection in laparoscopic gastric cancer surgery is mainly based on the D notation, namely D1, D2 and D0 surgery. The details are as follows:
In addition, the application of 4K laparoscopic system in radical total gastrectomy can achieve standardized, normalized and precise operation, and reduce the occurrence of complications.
After the implementation of the "Guidelines for Laparoscopic Gastric Cancer Surgery (2023 Edition)", several actual cases and research reports have demonstrated its effectiveness.
An article published on November 25, 2020 mentioned that 35 patients who underwent laparoscopic radical resection of mid-upper gastric cancer using the purse-string clamp method achieved good short-term results.
Another article published on August 25, 2023 discussed the application experience of intraoperative gastroscopy in laparoscopic gastric cancer surgery. Although it did not directly mention the "Guidelines for Laparoscopic Gastric Cancer Surgery (2023 Edition)", it may be related to the application of the guidelines.
Professor Xu Huimian mentioned in his article on January 9, 2024 that a recent single-arm clinical study in the United States found that the use of the da Vinci single-port robot to complete distal gastrectomy was effective, which also indirectly reflects the progress and application of laparoscopic technology.
3 Packing & Shipping:
Package detail: | Poly bag and special shockproof paper box. |
Delivery detail: | By air |
Contact Us at Any Time